Results 171 to 180 of about 148,724 (217)
Discovery of Potent and Orally Bioavailable Heterocycle-Based Cannabinoid CB1 Receptor Agonists
Novel 3-(1H-indol-3-yl)-1,2,4-oxadiazoles and -thiadiazoles were synthesized and found to be potent CB1 cannabinoid receptor agonists. The oral bioavailability of these compounds could be dramatically improved by optimization studies of the side chains ...
Grant Wishart +2 more
exaly +5 more sources
Novel tricyclic indole-3-carboxamides were synthesized as structurally restricted analogs of bicyclic indoles, and found to be potent CB1 cannabinoid receptor agonists.
Mark York, Glenn Walker, Darren Edwards
exaly +5 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Oximes short-acting CB1 receptor agonists
Bioorganic & Medicinal Chemistry, 2018New oximes short-acting CB1 agonists were explored by the introduction of an internal oxime and polar groups at the C3 alkyl tail of Δ8-THC. The scope of the research was to drastically alter two important physicochemical properties hydrophobicity (log P) and topological surface area (tPSA) of the compound, which play a critical role in tissue ...
Michael S. Malamas +8 more
openaire +2 more sources
AM630 is an inverse agonist at the human cannabinoid CB1 receptor
Life Sciences, 1998The present investigation examines WIN 55,212-2 and AM630 at the cloned human cannabinoid CB1 receptor stably expressed in Chinese hamster ovary (CHO) cells. The effect of various concentrations of WIN 55,212-2 and AM630 on basal [35S]GTPgammaS binding to cell membranes was determined.
R S, Landsman +5 more
openaire +2 more sources
SR141716A is an inverse agonist at the human cannabinoid CB1 receptor
European Journal of Pharmacology, 1997The effects of R(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4- benzoxazin-yl]-(1-napthalenyl)methanone mesylate (WIN 55,212-2) and N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-3-pyrazo le-carboxamide (SR141716A) on guanosine-5'-O-(3-[35S]thio)triphosphate ([35S]GTPgammaS) binding to membranes isolated from ...
R S, Landsman +4 more
openaire +2 more sources
CNS & Neurological Disorders - Drug Targets, 2011
Cannabinoids are antinociceptive in animal models of acute pain, tissue injury and nerve injury induced nociception and act via their cognate receptors, cannabinoid receptor 1 and 2. This review examines the underlying biology of the endocannabinoids and behavioural, neurophysiological, neuroanatomical evidence supporting the notion of pain modulation ...
Rashmi, Talwar, Vijay Kumar, Potluri
openaire +2 more sources
Cannabinoids are antinociceptive in animal models of acute pain, tissue injury and nerve injury induced nociception and act via their cognate receptors, cannabinoid receptor 1 and 2. This review examines the underlying biology of the endocannabinoids and behavioural, neurophysiological, neuroanatomical evidence supporting the notion of pain modulation ...
Rashmi, Talwar, Vijay Kumar, Potluri
openaire +2 more sources
Synthesis and SAR of 5,6-diarylpyridines as human CB1 inverse agonists
Bioorganic & Medicinal Chemistry Letters, 2005Structure-activity relationship studies for two series of 2-benzyloxy-5-(4-chlorophenyl)-6-(2,4-dichlorophenyl)pyridines having either a 3-cyano or 3-carboxamide moiety resulted in the preparation of the 2-(3,4-difluorobenzyloxy)-3-nitrile analog 10d and the 2-(3,4-difluorobenzyloxy)-3-(N-propylcarboxamide) analog 16c, (hCB1 IC(50)=1.3 and 1.7 nM ...
Laura C, Meurer +17 more
openaire +3 more sources
Alterations in behavioral flexibility by cannabinoid CB1 receptor agonists and antagonists
Psychopharmacology, 2006Cannabinoid CB1 receptors are expressed in the prefrontal cortex, but their role in mediating executive functions such as behavioral flexibility is unclear.The present study examined the effect of pharmacological activation or blockade of the cannabinoid CB1 receptors on behavioral flexibility using a strategy set-shifting task conducted on a cross ...
Matthew N, Hill +4 more
openaire +2 more sources
Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain
European Journal of Pharmacology, 1997We measured (-)-5-(1,1-dimethylheptyl)-2-[5-hydroxy-2-(3-hydroxypropyl)cyclohe xyl]-phenol (CP 55,940)-, (-)11-OH-delta8-tetrahydrocannabinol-dimethylheptyl (HU-210)-, anandamide- and delta9-tetrahydrocannabinol-stimulated G protein activation in mouse brain using the [35S]GTPgammaS functional assay.
T H, Burkey +6 more
openaire +2 more sources
Discovery of a novel class of selective human CB1 inverse agonists
Bioorganic & Medicinal Chemistry Letters, 2008Ligand-based virtual screening led to the discovery of a new class of potent inverse agonists of the human cannabinoid receptor 1, hCB(1), which are selective versus hCB(2). These CB(1) ligands present intriguing departures from a classical CB(1) antagonist pharmacophore. Elements of SAR are discussed in this context.
Nicolas, Foloppe +9 more
openaire +2 more sources

